WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (Nasdaq:ALTH) today reported results for its fiscal year ended December 31, 2007 and outlined its key objectives for 2008. For the year ended December 31, 2007, the Company reported a net loss of $39.4 million, or $0.60 per share, compared to a net loss of $30.2 million, or $0.55 per share, for 2006. For the year, net cash used in operating activities was $30.8 million. Cash, cash equivalents and investments in marketable securities as of December 31, 2007 totaled $57.8 million.
